Funding for Digital Health Ventures Drops Amid Shift to Early-Stage Startups

In 2024, U.S. digital health companies saw a decline in venture capital funding, securing $10.1 billion across 497 deals, down from $10.8 billion in over 500 deals the previous year, according to a Rock Health report. The drop indicates a shift in investor interest toward early-stage startups, with 86% of funding rounds directed at seed, Series A, and Series B companies. Meanwhile, established firms faced reduced deal sizes as investors exhibited caution amidst valuation challenges. Notably, artificial intelligence startups remained attractive, capturing 37% of the total funding, while median deal sizes for Series C and D rounds also decreased, highlighting ongoing changes in the funding landscape post-pandemic.

Opens on Healthcare Dive